Thursday, May 24, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
Challenges and advancements in QPCR analysis
Real-time quantitative PCR (QPCR) is now the benchmark technology for quantifying nucleic acids as traditional methods such as ribonuclease protection assay (RPA) become outdated and serve as ancillary techniques to QPCR.
No Comments
The Executive Roundtable
Kevin Hrusovsky of Caliper Life Sciences, Nick Hughes from PA Consulting Group, David Weber of Stratagene, and Whatman's Dr Jens Beator offer their views on pharma's beating heart: drug discovery.
No Comments
The hard cell: Genomics and the future of drug discovery
By Dr Christopher Austin of the National Human Genome Research Institute.
No Comments
Chips in
Why falling costs and maturing technology mean biochips can revolutionise drug discovery.
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.